TECH | Bio-TechneNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$72.67
+$0.01 (+0.01%)

Bio-Techne (TECH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $72.67 vs 50 $72.46 / 200 $63.17
Projection
No cross projected
Test
No active test
Last cross
Golden cross 24 Jul 2026 ยท projected 22 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $72.66 vs 50 $62.87 / 200 $67.82
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 24 Apr 2023 ยท projected 26 bars out ยท tested 7 bars

4-hour as of 3 Nov 16:00 ET

Price
above both $72.66 vs 50 $72.56 / 200 $70.86
Projection
No cross projected
Test
No active test
Last cross
Golden cross 29 Jun 2026 ยท projected 19 bars out

Cross history

29
crosses on record since 2018
14 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
24 Jul 2026Golden steepdaily22 bars outNot tested
29 Jun 2026Golden4-hour19 bars outNot tested
7 Apr 2026Death steepdaily28 bars out4 bar cross test
3 Mar 2026Death4-hour29 bars outNot tested
29 Oct 2025Golden steepdaily28 bars out2 bar cross test

About TECH

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$196M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.